1. Home
  2. AX vs PRAX Comparison

AX vs PRAX Comparison

Compare AX & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$82.19

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$179.36

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
PRAX
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.0B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
AX
PRAX
Price
$82.19
$179.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
13
Target Price
$96.86
$228.69
AVG Volume (30 Days)
266.1K
926.2K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.44
N/A
Revenue
$1,202,571,000.00
$7,463,000.00
Revenue This Year
$17.36
N/A
Revenue Next Year
$10.34
$44.43
P/E Ratio
$11.06
N/A
Revenue Growth
6.69
364.98
52 Week Low
$54.46
$26.70
52 Week High
$93.84
$206.71

Technical Indicators

Market Signals
Indicator
AX
PRAX
Relative Strength Index (RSI) 55.13 52.85
Support Level $81.48 $181.76
Resistance Level $83.43 $199.47
Average True Range (ATR) 2.29 14.96
MACD 0.59 -3.33
Stochastic Oscillator 83.01 47.05

Price Performance

Historical Comparison
AX
PRAX

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: